NCT Number: NCT02668614
Early Detection of Skin Cancer With Sensor Technology
Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion
- 18 years of age or older
Exclusion criteria
-Poor english fluency, Pregnancy
Treatment and study plan
Primary outcomes
-
Positive predictive value
Time frame: Immediately pre-biopsy
Sponsors and collaborators
Lead sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Registry information
Official study title
Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jan 29, 2016
- Registry last updated
- Nov 6, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
NCT01455363
Carcinoma, Carcinoma, Basal Cell
Paris, France
View Trial DetailsLaser Treatment of Basal Cell Carcinoma Under Imaging Guidance
NCT05138328
Carcinoma, Carcinoma, Basal Cell
Detroit, Michigan, United States
View Trial DetailsTreatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
NCT03897036
Carcinoma, Carcinoma, Basal Cell
Scottsdale, Arizona, United States
View Trial DetailsPD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
NCT03132636
Carcinoma, Carcinoma, Basal Cell
Phoenix, Arizona, United States
View Trial Details